Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial-Reference-Cited by-同舟云学术

Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial

Published:2023-08 Issue:8 Volume:22 Page:672-684
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Maynard George,Kannan Ramakrishnan,Liu Jian,Wang Weiwei,Lam Tu Kiet T,Wang Xingxing,Adamson Crista,Hackett Craig,Schwab Jan M,Liu Charles,Leslie Donald P,Chen David,Marino Ralph,Zafonte Ross,Flanders Adam,Block Gilbert,Smith Erika,Strittmatter Stephen M

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference46 articles.

1. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet Neurol,2019

2. Regulation of axonal regeneration after mammalian spinal cord injury;Zheng;Nature,2023

3. Axon regeneration in the peripheral and central nervous systems;Huebner;Results Probl Cell Differ,2009

4. Intrinsic Control of Axon Regeneration;He;Neuron,2016

5. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein;GrandPré;Nature,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of the Nogo-pathway in experimental spinal cord injury: a meta-analysis of 76 experimental treatments;Scientific Reports;2023-12-21

2. Nanomaterials as therapeutic agents to modulate astrocyte-mediated inflammation in spinal cord injury;Materials Today Bio;2023-12

3. Editorial: Update on current topics in spinal cord injury, trauma and rehabilitation;Current Opinion in Neurology;2023-11-09

4. Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial;Current Opinion in Neurology;2023-09-19

5. Blocking inhibitors of axon growth after spinal cord injury;The Lancet Neurology;2023-08